The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(2-fluoro-4-nitro-5-(4-(phenylsulfonyl)piperazin-1-yl)phenyl)azepane ID: ALA4875290
PubChem CID: 2913873
Max Phase: Preclinical
Molecular Formula: C22H27FN4O4S
Molecular Weight: 462.55
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=[N+]([O-])c1cc(F)c(N2CCCCCC2)cc1N1CCN(S(=O)(=O)c2ccccc2)CC1
Standard InChI: InChI=1S/C22H27FN4O4S/c23-19-16-22(27(28)29)21(17-20(19)24-10-6-1-2-7-11-24)25-12-14-26(15-13-25)32(30,31)18-8-4-3-5-9-18/h3-5,8-9,16-17H,1-2,6-7,10-15H2
Standard InChI Key: PHTDYGXLLYTXFY-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
33.4471 -5.3241 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.0426 -4.6184 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
32.6336 -5.3215 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.8025 -2.1668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8014 -2.9863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5094 -3.3953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2191 -2.9858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2162 -2.1632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5076 -1.7579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0969 -3.3921 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.9251 -3.3925 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.9244 -4.2107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6287 -4.6181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3382 -4.2118 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.3389 -3.3937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6301 -2.9818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9245 -1.7505 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.9215 -0.9334 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.6338 -2.1565 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.0947 -1.7583 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
33.7536 -4.2150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4585 -4.6285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1666 -4.2221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1688 -3.4041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4571 -2.9941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7519 -3.4028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1527 -4.1978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5560 -4.7527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4207 -2.9317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7528 -4.6357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6428 -3.1727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3485 -3.9316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
5 10 1 0
11 12 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
7 11 1 0
17 18 2 0
17 19 1 0
8 17 1 0
4 20 1 0
14 2 1 0
2 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
10 27 1 0
27 28 1 0
10 29 1 0
28 30 1 0
29 31 1 0
30 32 1 0
31 32 1 0
M CHG 2 17 1 19 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 462.55Molecular Weight (Monoisotopic): 462.1737AlogP: 3.63#Rotatable Bonds: 5Polar Surface Area: 87.00Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.25CX LogD: 4.25Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.50Np Likeness Score: -1.82
References 1. (2020) Methods and Compositions for Treating Cancer,